Analyst Price Targets — EXPO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 2, 2026 1:08 pm | Joshua Chan | UBS | $75.00 | $59.09 | StreetInsider | UBS Reiterates Neutral Rating on Exponent (EXPO) |
| February 9, 2026 11:46 am | Joshua Chan | UBS | $85.00 | $79.79 | TheFly | Exponent price target raised to $85 from $81 at UBS |
| December 15, 2025 12:38 pm | — | UBS | $81.00 | $73.64 | TheFly | Exponent price target raised to $81 from $76 at UBS |
| July 26, 2024 10:31 am | Tobey Sommer | Truist Financial | $120.00 | $105.54 | TheFly | Exponent price target raised to $120 from $100 at Truist |
| June 26, 2024 7:17 am | Joshua Chan | UBS | $88.00 | $94.44 | StreetInsider | UBS Reiterates Neutral Rating on Exponent (EXPO) |
Latest News for EXPO
MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2026 financial results for the period ended July 3, 2026 following the close of the market on Thursday, July 30, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial…
Exponent Inc. receives a buy rating, driven by its expert consulting model in high-stakes, complex technical domains. EXPO's value proposition lies in its deep technical talent, critical for problems where failure is costly and regulatory scrutiny is high. The AI debate is a catalyst: rising complexity in physical systems should increase demand for EXPO's services, not diminish it.
Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy
MENLO PARK, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson will participate in a fireside chat at the following investor conference:
Exponent is a market leader in scientific and engineering consulting, boasting a 13-year dividend growth streak and a fortress balance sheet. EXPO's fiscal 2026 outlook signals rising top and bottom lines, with AI-related demand driving proactive and reactive service growth. The stock trades at ~26.5x FY26E EPS, well below its 5-year average, suggesting undervaluation with a fair value estimate of $73.80 versus a…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EXPO.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.